Rivier J - Search Results

1

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.

Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, Erchegyi J, Rivier J, Mäcke HR, Reubi JC. Ginj M, et al. Among authors: rivier j. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16436-41. doi: 10.1073/pnas.0607761103. Epub 2006 Oct 20. Proc Natl Acad Sci U S A. 2006. PMID: 17056720 Free PMC article.

2

Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.

Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A, Reubi JC. Cescato R, et al. J Nucl Med. 2006 Mar;47(3):502-11. J Nucl Med. 2006. PMID: 16513620 Free article.

3

Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog.

Reubi JC, Erchegyi J, Cescato R, Waser B, Rivier JE. Reubi JC, et al. Among authors: rivier je. Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1551-8. doi: 10.1007/s00259-010-1445-x. Epub 2010 Apr 16. Eur J Nucl Med Mol Imaging. 2010. PMID: 20396884 Free PMC article.

4

SST3-selective potent peptidic somatostatin receptor antagonists.

Reubi JC, Schaer JC, Wenger S, Hoeger C, Erchegyi J, Waser B, Rivier J. Reubi JC, et al. Among authors: rivier j. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13973-8. doi: 10.1073/pnas.250483897. Proc Natl Acad Sci U S A. 2000. PMID: 11095748 Free PMC article.

5

First clinical evidence that imaging with somatostatin receptor antagonists is feasible.

Wild D, Fani M, Behe M, Brink I, Rivier JE, Reubi JC, Maecke HR, Weber WA. Wild D, et al. J Nucl Med. 2011 Sep;52(9):1412-7. doi: 10.2967/jnumed.111.088922. Epub 2011 Aug 18. J Nucl Med. 2011. PMID: 21852357 Free article.

6

Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study.

Wild D, Fani M, Fischer R, Del Pozzo L, Kaul F, Krebs S, Fischer R, Rivier JE, Reubi JC, Maecke HR, Weber WA. Wild D, et al. J Nucl Med. 2014 Aug;55(8):1248-52. doi: 10.2967/jnumed.114.138834. Epub 2014 Jun 24. J Nucl Med. 2014. PMID: 24963127 Free article.

7

Safety, Biodistribution, and Radiation Dosimetry of ⁶⁸Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study.

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, Wild D. Nicolas GP, et al. Among authors: rivier jef. J Nucl Med. 2018 Jun;59(6):909-914. doi: 10.2967/jnumed.117.199737. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025985 Free article. Clinical Trial.

8

Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.

Grace CR, Durrer L, Koerber SC, Erchegyi J, Reubi JC, Rivier JE, Riek R. Grace CR, et al. Among authors: rivier je. J Med Chem. 2005 Jan 27;48(2):523-33. doi: 10.1021/jm049518u. J Med Chem. 2005. PMID: 15658866

9

Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity.

Grace CR, Erchegyi J, Samant M, Cescato R, Piccand V, Riek R, Reubi JC, Rivier JE. Grace CR, et al. Among authors: rivier je. J Med Chem. 2008 May 8;51(9):2676-81. doi: 10.1021/jm701445q. Epub 2008 Apr 12. J Med Chem. 2008. PMID: 18410083 Free PMC article.

10

Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.

Erchegyi J, Grace CR, Samant M, Cescato R, Piccand V, Riek R, Reubi JC, Rivier JE. Erchegyi J, et al. Among authors: rivier je. J Med Chem. 2008 May 8;51(9):2668-75. doi: 10.1021/jm701444y. Epub 2008 Apr 12. J Med Chem. 2008. PMID: 18410084 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

873 results

Search Page

Filters